<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02839551</url>
  </required_header>
  <id_info>
    <org_study_id>9611</org_study_id>
    <nct_id>NCT02839551</nct_id>
  </id_info>
  <brief_title>Optimal Doses for Drug Provocation Tests to Beta-lactams</brief_title>
  <acronym>NewBL</acronym>
  <official_title>Optimal Step Doses for Drug Provocation Tests to Prove Beta-lactam Hypersensitivity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Drug provocation tests (DPT) are widely in case of suspicion of drug hypersensitivity (and in
      the absence of contraindications), but there are no standardized protocols and most groups
      use hypothesis (clinically-driven) protocols.

      investigators used 20 year experience in drug hypersensitivity to analyse retrospectively 171
      patients (accounting for 182 positive DPT to beta-lactams). Using survival analysis, they
      identified optimal doses to include in a data-driven protocol. This data-driven protocol will
      be applied to new prospective patients, to test its safety and benefits (gain in time,
      hospital and patient benefits).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of the new simplified drug provocation test</measure>
    <time_frame>up to 1 hour</time_frame>
    <description>Assessment of the non inferiority of the new drug provocation test compared to the present drug provocation test</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Drug Hypersensitivity</condition>
  <arm_group>
    <arm_group_label>Simplified drug provocation test</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Assessment of the Hypersensitivity to betalactams by simplified drug provocation test</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>simplified drug provocation test</intervention_name>
    <description>Assessment of the Hypersensitivity to betalactams by simplified drug provocation test</description>
    <arm_group_label>Simplified drug provocation test</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with positive Drug Provocation Test (DPT) to beta-lactams

        Exclusion Criteria:

          -  contra-indications to DPT

          -  refusal of participation

          -  vulnerable patients according to French regulation
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University hospital of Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pascal Demoly, MD,PhD</last_name>
      <email>pascal.demoly@inserm.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 18, 2016</study_first_submitted>
  <study_first_submitted_qc>July 18, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 21, 2016</study_first_posted>
  <last_update_submitted>July 21, 2016</last_update_submitted>
  <last_update_submitted_qc>July 21, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Betalactams</keyword>
  <keyword>Drug hypersensitivity</keyword>
  <keyword>Drug provocation test</keyword>
  <keyword>Reactive dose</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypersensitivity</mesh_term>
    <mesh_term>Drug Hypersensitivity</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lactams</mesh_term>
    <mesh_term>beta-Lactams</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

